Radioactive Iodine Uptake
RAIU
Description
"Radioactive Iodine Uptake (RAIU)" test evaluates how much iodine your thyroid absorbs, offering insight into hormone production. It’s often used to diagnose thyroid disorders such as hyperthyroidism, Graves’ disease, or thyroid nodules. After a small dose of radioactive iodine is swallowed, a scanner measures how much your thyroid takes in. Abnormal uptake may indicate overactivity, inflammation, or iodine imbalance. Results help guide treatment, including medication, iodine therapy, or surgery, and support accurate long-term thyroid care.
Category
Hormones
Procedure
Non-Invasive
Sample Type
No biological sample is needed for this test.
Units
Percentage
Procedure Category
Ingest, Scan
Test Group
Complete Thyroid Group
Test Group Description
Chronic Illness Group: This group encompasses a range of tests specifically tailored to assess markers associated with chronic health conditions, providing comprehensive insights into the management and monitoring of chronic illnesses.
Optimal Range
For All Individuals:
Conventional Unit: Not Available (6 Hours) | Not Available (24 Hours)
SI Unit: Not Applicable
Normal Range
For All Individuals:
Conventional Unit: 5.00–15.00% (6 Hours) | 10.00–30.00% (24 Hours)
SI Unit: Not Applicable
Results That Differ From The Norm (Direct and Indirect Causes)
Abnormal results may indicate:
Autoimmune thyroiditis (Inflammation of the thyroid gland due to autoimmune processes)
Congenital thyroid hormone synthesis defect (Genetic disorder affecting thyroid hormone production)
Destructive thyroiditis (Inflammation leading to destruction of thyroid tissue)
Ectopic thyroid tissue (Thyroid tissue found outside its normal location)
- ...
Key Reasons For Testing
Thyroid Function Evaluation: Assesses iodine uptake to evaluate thyroid metabolism and function.
Diagnosis of Hyperthyroidism: Identifies elevated iodine uptake levels characteristic of hyperthyroidism.
Differentiation of Thyroid Disorders: Distinguishes between conditions like Graves' disease, toxic adenoma, and multinodular goiter.
Treatment Planning for Hyperthyroidism: Guides radioactive iodine therapy dosage for targeting overactive thyroid tissue.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Robbins J, Merino MJ, Boice JD Jr. Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med.1991;115(2):133-147.
[2] Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593-646.
[3] Pearce EN, Hennessey JV, McDermott MT. Thyroid function testing in patients with thyrotoxicosis. Endocr Pract. 2010;16(2):233-239.
[4] Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid.2009;19(11):1167-1214.
[5] Haugen BR. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133.
[6] Ross DS, Burch HB, Cooper DS, et al. American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421.
[7] Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005;90(9):5483-5488.
[8] Braverman LE, Utiger RD. Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Text. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
[9] Greenspan FS, Forsham PH. The diagnosis of thyrotoxicosis. N Engl J Med. 1964;271:1051-1057.
[10] McDermott MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab. 2001;86(10):4585-4590.
[11] Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med.2001;344(7):501-509.
[12] Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86(4):1447-1463.
[13] Miller JM, Hamburger JI, Kini SR. Diagnostic accuracy of fine needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab. 1979;48(5):856-860.